Report cover image

Global Pharmaceutical Grade CBD Oil Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031

Publisher APO Research, Inc.
Published Aug 16, 2025
Length 198 Pages
SKU # APRC20355962

Description

Summary

According to APO Research, The global Pharmaceutical Grade CBD Oil market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Pharmaceutical Grade CBD Oil is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Pharmaceutical Grade CBD Oil is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Pharmaceutical Grade CBD Oil is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Pharmaceutical Grade CBD Oil is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Pharmaceutical Grade CBD Oil include Absolute Terps, Aphria, Cannavest, Canopy Growth Corporation, CBD American Shaman, Charlotte's Web, Emblem Cannabis Oils, ENDOCA and Folium Biosciences, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Pharmaceutical Grade CBD Oil, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020-2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Pharmaceutical Grade CBD Oil, also provides the sales of main regions and countries. Of the upcoming market potential for Pharmaceutical Grade CBD Oil, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Pharmaceutical Grade CBD Oil sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Pharmaceutical Grade CBD Oil market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Pharmaceutical Grade CBD Oil sales, projected growth trends, production technology, application and end-user industry.

Pharmaceutical Grade CBD Oil Segment by Company

Absolute Terps
Aphria
Cannavest
Canopy Growth Corporation
CBD American Shaman
Charlotte's Web
Emblem Cannabis Oils
ENDOCA
Folium Biosciences
GL Brands, Inc.
Green Road
HempLife Today
K.I.N.D. Concentrates
Kazmira
Medical Marijuana, Inc.
NuLeaf Naturals
PHARM-CBD, LLC
The Lab
Whistler
Pharmaceutical Grade CBD Oil Segment by Type

Full Spectrum CBD Oil
Broad Spectrum CBD Oil
Pharmaceutical Grade CBD Oil Segment by Application

Anxiety
Diabetes
Fibromyalgia
Others
Pharmaceutical Grade CBD Oil Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmaceutical Grade CBD Oil market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pharmaceutical Grade CBD Oil and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmaceutical Grade CBD Oil.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Pharmaceutical Grade CBD Oil market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2020-2031).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pharmaceutical Grade CBD Oil manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Pharmaceutical Grade CBD Oil in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Pharmaceutical Grade CBD Oil in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report

Table of Contents

198 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Pharmaceutical Grade CBD Oil Market Size, 2020 VS 2024 VS 2031
1.3 Global Pharmaceutical Grade CBD Oil Market Size Estimates and Forecasts (2020-2031)
1.4 Global Pharmaceutical Grade CBD Oil Sales Estimates and Forecasts (2020-2031)
1.5 Global Pharmaceutical Grade CBD Oil Market Average Price (2020-2031)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 Global Pharmaceutical Grade CBD Oil Market Dynamics
2.1 Pharmaceutical Grade CBD Oil Industry Trends
2.2 Pharmaceutical Grade CBD Oil Industry Drivers
2.3 Pharmaceutical Grade CBD Oil Industry Opportunities and Challenges
2.4 Pharmaceutical Grade CBD Oil Industry Restraints
3 Pharmaceutical Grade CBD Oil Market by Manufacturers
3.1 Global Pharmaceutical Grade CBD Oil Revenue by Manufacturers (2020-2025)
3.2 Global Pharmaceutical Grade CBD Oil Sales by Manufacturers (2020-2025)
3.3 Global Pharmaceutical Grade CBD Oil Average Sales Price by Manufacturers (2020-2025)
3.4 Global Pharmaceutical Grade CBD Oil Industry Manufacturers Ranking, 2023 VS 2024 VS 2025
3.5 Global Pharmaceutical Grade CBD Oil Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Pharmaceutical Grade CBD Oil Manufacturers, Product Type & Application
3.7 Global Pharmaceutical Grade CBD Oil Manufacturers Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Pharmaceutical Grade CBD Oil Market CR5 and HHI
3.8.2 Global Top 5 and 10 Pharmaceutical Grade CBD Oil Players Market Share by Revenue in 2024
3.8.3 2024 Pharmaceutical Grade CBD Oil Tier 1, Tier 2, and Tier 3
4 Pharmaceutical Grade CBD Oil Market by Type
4.1 Pharmaceutical Grade CBD Oil Type Introduction
4.1.1 Full Spectrum CBD Oil
4.1.2 Broad Spectrum CBD Oil
4.2 Global Pharmaceutical Grade CBD Oil Sales by Type
4.2.1 Global Pharmaceutical Grade CBD Oil Sales by Type (2020 VS 2024 VS 2031)
4.2.2 Global Pharmaceutical Grade CBD Oil Sales by Type (2020-2031)
4.2.3 Global Pharmaceutical Grade CBD Oil Sales Market Share by Type (2020-2031)
4.3 Global Pharmaceutical Grade CBD Oil Revenue by Type
4.3.1 Global Pharmaceutical Grade CBD Oil Revenue by Type (2020 VS 2024 VS 2031)
4.3.2 Global Pharmaceutical Grade CBD Oil Revenue by Type (2020-2031)
4.3.3 Global Pharmaceutical Grade CBD Oil Revenue Market Share by Type (2020-2031)
5 Pharmaceutical Grade CBD Oil Market by Application
5.1 Pharmaceutical Grade CBD Oil Application Introduction
5.1.1 Anxiety
5.1.2 Diabetes
5.1.3 Fibromyalgia
5.1.4 Others
5.2 Global Pharmaceutical Grade CBD Oil Sales by Application
5.2.1 Global Pharmaceutical Grade CBD Oil Sales by Application (2020 VS 2024 VS 2031)
5.2.2 Global Pharmaceutical Grade CBD Oil Sales by Application (2020-2031)
5.2.3 Global Pharmaceutical Grade CBD Oil Sales Market Share by Application (2020-2031)
5.3 Global Pharmaceutical Grade CBD Oil Revenue by Application
5.3.1 Global Pharmaceutical Grade CBD Oil Revenue by Application (2020 VS 2024 VS 2031)
5.3.2 Global Pharmaceutical Grade CBD Oil Revenue by Application (2020-2031)
5.3.3 Global Pharmaceutical Grade CBD Oil Revenue Market Share by Application (2020-2031)
6 Global Pharmaceutical Grade CBD Oil Sales by Region
6.1 Global Pharmaceutical Grade CBD Oil Sales by Region: 2020 VS 2024 VS 2031
6.2 Global Pharmaceutical Grade CBD Oil Sales by Region (2020-2031)
6.2.1 Global Pharmaceutical Grade CBD Oil Sales by Region (2020-2025)
6.2.2 Global Pharmaceutical Grade CBD Oil Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America Pharmaceutical Grade CBD Oil Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.3.2 North America Pharmaceutical Grade CBD Oil Sales by Country (2020-2031)
6.3.3 U.S.
6.3.4 Canada
6.3.5 Mexico
6.4 Europe
6.4.1 Europe Pharmaceutical Grade CBD Oil Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.4.2 Europe Pharmaceutical Grade CBD Oil Sales by Country (2020-2031)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific Pharmaceutical Grade CBD Oil Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.5.2 Asia Pacific Pharmaceutical Grade CBD Oil Sales by Country (2020-2031)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 South America, Middle East and Africa
6.6.1 South America, Middle East and Africa Pharmaceutical Grade CBD Oil Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.6.2 South America, Middle East and Africa Pharmaceutical Grade CBD Oil Sales by Country (2020-2031)
6.6.3 Brazil
6.6.4 South Africa
6.6.5 Saudi Arabia
6.6.6 Turkey
6.6.6 Argentina
6.6.6 UAE
6.6.6 Egypt
6.6.6 Chile
7 Global Pharmaceutical Grade CBD Oil Revenue by Region
7.1 Global Pharmaceutical Grade CBD Oil Revenue by Region
7.1.1 Global Pharmaceutical Grade CBD Oil Revenue by Region: 2020 VS 2024 VS 2031
7.1.2 Global Pharmaceutical Grade CBD Oil Revenue by Region (2020-2025)
7.1.3 Global Pharmaceutical Grade CBD Oil Revenue by Region (2026-2031)
7.1.4 Global Pharmaceutical Grade CBD Oil Revenue Market Share by Region (2020-2031)
7.2 North America
7.2.1 North America Pharmaceutical Grade CBD Oil Revenue (2020-2031)
7.2.2 North America Pharmaceutical Grade CBD Oil Revenue Share by Country: 2020 VS 2024 VS 2031
7.3 Europe
7.3.1 Europe Pharmaceutical Grade CBD Oil Revenue (2020-2031)
7.3.2 Europe Pharmaceutical Grade CBD Oil Revenue Share by Country: 2020 VS 2024 VS 2031
7.4 Asia-Pacific
7.4.1 Asia-Pacific Pharmaceutical Grade CBD Oil Revenue (2020-2031)
7.4.2 Asia-Pacific Pharmaceutical Grade CBD Oil Revenue Share by Country: 2020 VS 2024 VS 2031
7.5 South America, Middle East and Africa
7.5.1 South America, Middle East and Africa Pharmaceutical Grade CBD Oil Revenue (2020-2031)
7.5.2 South America, Middle East and Africa Pharmaceutical Grade CBD Oil Revenue Share by Country: 2020 VS 2024 VS 2031
8 Company Profiles
8.1 Absolute Terps
8.1.1 Absolute Terps Comapny Information
8.1.2 Absolute Terps Business Overview
8.1.3 Absolute Terps Pharmaceutical Grade CBD Oil Sales, Price, Revenue and Gross Margin (2020-2025)
8.1.4 Absolute Terps Pharmaceutical Grade CBD Oil Product Portfolio
8.1.5 Absolute Terps Recent Developments
8.2 Aphria
8.2.1 Aphria Comapny Information
8.2.2 Aphria Business Overview
8.2.3 Aphria Pharmaceutical Grade CBD Oil Sales, Price, Revenue and Gross Margin (2020-2025)
8.2.4 Aphria Pharmaceutical Grade CBD Oil Product Portfolio
8.2.5 Aphria Recent Developments
8.3 Cannavest
8.3.1 Cannavest Comapny Information
8.3.2 Cannavest Business Overview
8.3.3 Cannavest Pharmaceutical Grade CBD Oil Sales, Price, Revenue and Gross Margin (2020-2025)
8.3.4 Cannavest Pharmaceutical Grade CBD Oil Product Portfolio
8.3.5 Cannavest Recent Developments
8.4 Canopy Growth Corporation
8.4.1 Canopy Growth Corporation Comapny Information
8.4.2 Canopy Growth Corporation Business Overview
8.4.3 Canopy Growth Corporation Pharmaceutical Grade CBD Oil Sales, Price, Revenue and Gross Margin (2020-2025)
8.4.4 Canopy Growth Corporation Pharmaceutical Grade CBD Oil Product Portfolio
8.4.5 Canopy Growth Corporation Recent Developments
8.5 CBD American Shaman
8.5.1 CBD American Shaman Comapny Information
8.5.2 CBD American Shaman Business Overview
8.5.3 CBD American Shaman Pharmaceutical Grade CBD Oil Sales, Price, Revenue and Gross Margin (2020-2025)
8.5.4 CBD American Shaman Pharmaceutical Grade CBD Oil Product Portfolio
8.5.5 CBD American Shaman Recent Developments
8.6 Charlotte's Web
8.6.1 Charlotte's Web Comapny Information
8.6.2 Charlotte's Web Business Overview
8.6.3 Charlotte's Web Pharmaceutical Grade CBD Oil Sales, Price, Revenue and Gross Margin (2020-2025)
8.6.4 Charlotte's Web Pharmaceutical Grade CBD Oil Product Portfolio
8.6.5 Charlotte's Web Recent Developments
8.7 Emblem Cannabis Oils
8.7.1 Emblem Cannabis Oils Comapny Information
8.7.2 Emblem Cannabis Oils Business Overview
8.7.3 Emblem Cannabis Oils Pharmaceutical Grade CBD Oil Sales, Price, Revenue and Gross Margin (2020-2025)
8.7.4 Emblem Cannabis Oils Pharmaceutical Grade CBD Oil Product Portfolio
8.7.5 Emblem Cannabis Oils Recent Developments
8.8 ENDOCA
8.8.1 ENDOCA Comapny Information
8.8.2 ENDOCA Business Overview
8.8.3 ENDOCA Pharmaceutical Grade CBD Oil Sales, Price, Revenue and Gross Margin (2020-2025)
8.8.4 ENDOCA Pharmaceutical Grade CBD Oil Product Portfolio
8.8.5 ENDOCA Recent Developments
8.9 Folium Biosciences
8.9.1 Folium Biosciences Comapny Information
8.9.2 Folium Biosciences Business Overview
8.9.3 Folium Biosciences Pharmaceutical Grade CBD Oil Sales, Price, Revenue and Gross Margin (2020-2025)
8.9.4 Folium Biosciences Pharmaceutical Grade CBD Oil Product Portfolio
8.9.5 Folium Biosciences Recent Developments
8.10 GL Brands, Inc.
8.10.1 GL Brands, Inc. Comapny Information
8.10.2 GL Brands, Inc. Business Overview
8.10.3 GL Brands, Inc. Pharmaceutical Grade CBD Oil Sales, Price, Revenue and Gross Margin (2020-2025)
8.10.4 GL Brands, Inc. Pharmaceutical Grade CBD Oil Product Portfolio
8.10.5 GL Brands, Inc. Recent Developments
8.11 Green Road
8.11.1 Green Road Comapny Information
8.11.2 Green Road Business Overview
8.11.3 Green Road Pharmaceutical Grade CBD Oil Sales, Price, Revenue and Gross Margin (2020-2025)
8.11.4 Green Road Pharmaceutical Grade CBD Oil Product Portfolio
8.11.5 Green Road Recent Developments
8.12 HempLife Today
8.12.1 HempLife Today Comapny Information
8.12.2 HempLife Today Business Overview
8.12.3 HempLife Today Pharmaceutical Grade CBD Oil Sales, Price, Revenue and Gross Margin (2020-2025)
8.12.4 HempLife Today Pharmaceutical Grade CBD Oil Product Portfolio
8.12.5 HempLife Today Recent Developments
8.13 K.I.N.D. Concentrates
8.13.1 K.I.N.D. Concentrates Comapny Information
8.13.2 K.I.N.D. Concentrates Business Overview
8.13.3 K.I.N.D. Concentrates Pharmaceutical Grade CBD Oil Sales, Price, Revenue and Gross Margin (2020-2025)
8.13.4 K.I.N.D. Concentrates Pharmaceutical Grade CBD Oil Product Portfolio
8.13.5 K.I.N.D. Concentrates Recent Developments
8.14 Kazmira
8.14.1 Kazmira Comapny Information
8.14.2 Kazmira Business Overview
8.14.3 Kazmira Pharmaceutical Grade CBD Oil Sales, Price, Revenue and Gross Margin (2020-2025)
8.14.4 Kazmira Pharmaceutical Grade CBD Oil Product Portfolio
8.14.5 Kazmira Recent Developments
8.15 Medical Marijuana, Inc.
8.15.1 Medical Marijuana, Inc. Comapny Information
8.15.2 Medical Marijuana, Inc. Business Overview
8.15.3 Medical Marijuana, Inc. Pharmaceutical Grade CBD Oil Sales, Price, Revenue and Gross Margin (2020-2025)
8.15.4 Medical Marijuana, Inc. Pharmaceutical Grade CBD Oil Product Portfolio
8.15.5 Medical Marijuana, Inc. Recent Developments
8.16 NuLeaf Naturals
8.16.1 NuLeaf Naturals Comapny Information
8.16.2 NuLeaf Naturals Business Overview
8.16.3 NuLeaf Naturals Pharmaceutical Grade CBD Oil Sales, Price, Revenue and Gross Margin (2020-2025)
8.16.4 NuLeaf Naturals Pharmaceutical Grade CBD Oil Product Portfolio
8.16.5 NuLeaf Naturals Recent Developments
8.17 PHARM-CBD, LLC
8.17.1 PHARM-CBD, LLC Comapny Information
8.17.2 PHARM-CBD, LLC Business Overview
8.17.3 PHARM-CBD, LLC Pharmaceutical Grade CBD Oil Sales, Price, Revenue and Gross Margin (2020-2025)
8.17.4 PHARM-CBD, LLC Pharmaceutical Grade CBD Oil Product Portfolio
8.17.5 PHARM-CBD, LLC Recent Developments
8.18 The Lab
8.18.1 The Lab Comapny Information
8.18.2 The Lab Business Overview
8.18.3 The Lab Pharmaceutical Grade CBD Oil Sales, Price, Revenue and Gross Margin (2020-2025)
8.18.4 The Lab Pharmaceutical Grade CBD Oil Product Portfolio
8.18.5 The Lab Recent Developments
8.19 Whistler
8.19.1 Whistler Comapny Information
8.19.2 Whistler Business Overview
8.19.3 Whistler Pharmaceutical Grade CBD Oil Sales, Price, Revenue and Gross Margin (2020-2025)
8.19.4 Whistler Pharmaceutical Grade CBD Oil Product Portfolio
8.19.5 Whistler Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Pharmaceutical Grade CBD Oil Value Chain Analysis
9.1.1 Pharmaceutical Grade CBD Oil Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Pharmaceutical Grade CBD Oil Production Mode & Process
9.2 Pharmaceutical Grade CBD Oil Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Pharmaceutical Grade CBD Oil Distributors
9.2.3 Pharmaceutical Grade CBD Oil Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.